Table 4.
Study | Disease Group | No. of Patients | Response Rate |
Absolute Difference | Disagreement |
||
---|---|---|---|---|---|---|---|
All Lesions | Longest 2 | No. | % | ||||
N0043 | GI | 38 | 11 | 8 | 3 | 1 | 2.6 |
N9921 | Lung | 50 | 12 | 14 | 2 | 1 | 2.0 |
N9932 | Breast | 48 | 60 | 60 | 0 | 0 | 0.0 |
N9941 | GI | 46 | 26 | 26 | 0 | 0 | 0.0 |
N0026 | Lung | 37 | 14 | 14 | 0 | 0 | 0.0 |
N0021 | Mesothelioma | 21 | 10 | 10 | 0 | 0 | 0.0 |
N0022 | Lung | 54 | 6 | 6 | 0 | 0 | 0.0 |
N0032 | Breast | 20 | 5 | 5 | 0 | 0 | 0.0 |
N0031 | Breast | 23 | 4 | 4 | 0 | 0 | 0.0 |
N0042 | GI | 26 | 4 | 4 | 0 | 0 | 0.0 |
N9946 | GI | 35 | 3 | 3 | 0 | 0 | 0.0 |
N9975 | Melanoma | 27 | 0 | 0 | 0 | 0 | 0.0 |
NOTE. Studies with N ≥ 20.